12:00 AM
 | 
Jan 30, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Metyrapone regulatory update

Novartis disclosed in its 4Q11 earnings that Japan approved Metopirone metyrapone to treat Cushing's...

Read the full 47 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >